Xia Y - Search Results

1

Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma.

Zhao M, Zhan C, Li M, Yang X, Yang X, Zhang Y, Lin M, Xia Y, Feng M, Wang Q. Zhao M, et al. Among authors: xia y. J Thorac Dis. 2018 Jan;10(1):398-407. doi: 10.21037/jtd.2017.12.68. J Thorac Dis. 2018. PMID: 29600072 Free PMC article.

2

Targeting CREB Pathway Suppresses Small Cell Lung Cancer.

Xia Y, Zhan C, Feng M, Leblanc M, Ke E, Yeddula N, Verma IM. Xia Y, et al. Mol Cancer Res. 2018 May;16(5):825-832. doi: 10.1158/1541-7786.MCR-17-0576. Epub 2018 Mar 9. Mol Cancer Res. 2018. PMID: 29523765 Free PMC article.

3

Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.

Yeddula N, Xia Y, Ke E, Beumer J, Verma IM. Yeddula N, et al. Among authors: xia y. Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6476-85. doi: 10.1073/pnas.1520110112. Epub 2015 Nov 5. Proc Natl Acad Sci U S A. 2015. PMID: 26542681 Free PMC article.

4

Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.

Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma IM. Xia Y, et al. Nat Cell Biol. 2012 Feb 12;14(3):257-65. doi: 10.1038/ncb2428. Nat Cell Biol. 2012. PMID: 22327365 Free PMC article.

5

Targeting NF-κB in glioblastoma: A therapeutic approach.

Friedmann-Morvinski D, Narasimamurthy R, Xia Y, Myskiw C, Soda Y, Verma IM. Friedmann-Morvinski D, et al. Among authors: xia y. Sci Adv. 2016 Jan 8;2(1):e1501292. doi: 10.1126/sciadv.1501292. eCollection 2016 Jan. Sci Adv. 2016. PMID: 26824076 Free PMC article.

6

NF-κB, an active player in human cancers.

Xia Y, Shen S, Verma IM. Xia Y, et al. Cancer Immunol Res. 2014 Sep;2(9):823-30. doi: 10.1158/2326-6066.CIR-14-0112. Cancer Immunol Res. 2014. PMID: 25187272 Free PMC article. Review.

7

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin.

Xia Y, Liu YL, Xie Y, Zhu W, Guerra F, Shen S, Yeddula N, Fischer W, Low W, Zhou X, Zhang Y, Oldfield E, Verma IM. Xia Y, et al. Sci Transl Med. 2014 Nov 19;6(263):263ra161. doi: 10.1126/scitranslmed.3010382. Sci Transl Med. 2014. PMID: 25411474 Free PMC article.

8

IKK biology.

Liu F, Xia Y, Parker AS, Verma IM. Liu F, et al. Among authors: xia y. Immunol Rev. 2012 Mar;246(1):239-53. doi: 10.1111/j.1600-065X.2012.01107.x. Immunol Rev. 2012. PMID: 22435559 Free PMC article. Review.

9

Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.

Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar VB, Verma IM. Xia Y, et al. Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2629-34. doi: 10.1073/pnas.0812256106. Epub 2009 Feb 5. Proc Natl Acad Sci U S A. 2009. PMID: 19196987 Free PMC article.

10

Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation.

Suzuki K, Murphy SH, Xia Y, Yokota M, Nakagomi D, Liu F, Verma IM, Nakajima H. Suzuki K, et al. Among authors: xia y. PLoS One. 2011;6(9):e25412. doi: 10.1371/journal.pone.0025412. Epub 2011 Sep 23. PLoS One. 2011. PMID: 21966524 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,018 results

Search Page